tiprankstipranks
Advertisement
Advertisement

TAK Stock Latest News

Takeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story
Company AnnouncementsTakeda’s New Mezagitamab Trial Targets High-Risk Kidney Rejection, Bolstering Long-Term Pipeline Story
54m ago
TAK
Takeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch
PremiumCompany Announcements
Takeda’s Real-World Maribavir Study in Argentina: What Investors Should Watch
54m ago
TAK
Innovent Biologics announces results from PoC study of IBI363
PremiumThe Fly
Innovent Biologics announces results from PoC study of IBI363
4d ago
TAK
Takeda to Revise FY2025 IFRS Earnings Report After U.S. AMITIZA Antitrust Verdict
PremiumCompany Announcements
Takeda to Revise FY2025 IFRS Earnings Report After U.S. AMITIZA Antitrust Verdict
9d ago
6K
TAK
Takeda Links Executive Pay to R&D Progress and TSR as FY2025 Results Reset Growth Path
PremiumCompany Announcements
Takeda Links Executive Pay to R&D Progress and TSR as FY2025 Results Reset Growth Path
9d ago
6K
TAK
Takeda CEO-Elect Julie Kim Sets Two-Horizon Growth Plan on Back of Strong FY2025 Pipeline and Results
PremiumCompany AnnouncementsTakeda CEO-Elect Julie Kim Sets Two-Horizon Growth Plan on Back of Strong FY2025 Pipeline and Results
9d ago
6K
TAK
Takeda Details IFRS-Based Financial Notes and Group Restructuring in May 2026 Filing
Premium
Company Announcements
Takeda Details IFRS-Based Financial Notes and Group Restructuring in May 2026 Filing
9d ago
6K
TAK
Takeda Sets June 24, 2026 Date for 150th Shareholders’ Meeting and Details Governance Agenda
Premium
Company Announcements
Takeda Sets June 24, 2026 Date for 150th Shareholders’ Meeting and Details Governance Agenda
9d ago
6K
TAK
Takeda Expands Maribavir Into Pediatric CMV, Extending Long-Term Upside Potential
PremiumCompany Announcements
Takeda Expands Maribavir Into Pediatric CMV, Extending Long-Term Upside Potential
13d ago
TAK
Takeda Expands Real-World Data on OBIZUR, Supporting Its Rare Disease Strategy
PremiumCompany Announcements
Takeda Expands Real-World Data on OBIZUR, Supporting Its Rare Disease Strategy
13d ago
TAK
Takeda Earnings Call: Pipeline Strength Amid Profit Squeeze
PremiumCompany Announcements
Takeda Earnings Call: Pipeline Strength Amid Profit Squeeze
14d ago
TAK
Jury finds Takeda caused about $885M in damages over generic delay, Reuters says
PremiumThe Fly
Jury finds Takeda caused about $885M in damages over generic delay, Reuters says
17d ago
TAK
Takeda told to pay hundreds of millions for generic drug delay, Bloomberg says
PremiumThe FlyTakeda told to pay hundreds of millions for generic drug delay, Bloomberg says
17d ago
TAK
Takeda ordered by pay hundreds of millions in antitrust case, Bloomberg says
Premium
The Fly
Takeda ordered by pay hundreds of millions in antitrust case, Bloomberg says
17d ago
TAK
Trump Trade: Trump says Xi agreed to buy 200 jets from Boeing
Premium
The Fly
Trump Trade: Trump says Xi agreed to buy 200 jets from Boeing
20d ago
BA
SPY
Justice Department announces $13.67M civil settlement with Takeda
PremiumThe Fly
Justice Department announces $13.67M civil settlement with Takeda
21d ago
TAK
These Are the Stocks Reporting Earnings Today – May 13, 2026
PremiumMarket News
These Are the Stocks Reporting Earnings Today – May 13, 2026
22d ago
MFC
STN
TAK Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
TAK Upcoming Earnings Report: What to Expect?
24d ago
TAK
Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions
PremiumCompany Announcements
Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions
28d ago
TAK
Takeda Advances Pediatric ENTYVIO Study, Supporting Long-Term Growth Potential
PremiumCompany AnnouncementsTakeda Advances Pediatric ENTYVIO Study, Supporting Long-Term Growth Potential
28d ago
TAK
Takeda announces TAK-881-3001 trial in PID met primary endpoint
Premium
The Fly
Takeda announces TAK-881-3001 trial in PID met primary endpoint
1M ago
TAK
Takeda’s SPOTLITE Study Wraps Up, Sharpening the View on Complex Fistula Care
Premium
Company Announcements
Takeda’s SPOTLITE Study Wraps Up, Sharpening the View on Complex Fistula Care
1M ago
TAK

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >